Prothena (PRTA)
(Delayed Data from NSDQ)
$8.18 USD
+0.12 (1.49%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $8.19 +0.01 (0.12%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Prothena Corporation plc has a PEG ratio of 14.76 compared to the Medical - Biomedical and Genetics industry's PEG ratio of 1.08.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
PRTA 8.18 +0.12(1.49%)
Will PRTA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PRTA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PRTA
Prothena Down 40% Year to Date: What Lies Ahead for the Stock?
Prothena (PRTA) Up 17.6% Since Last Earnings Report: Can It Continue?
PRTA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Prothena (PRTA) Reports Q2 Loss, Lags Revenue Estimates
PTC Therapeutics (PTCT) Surges 11.2%: Is This an Indication of Further Gains?
Earnings Preview: Rhythm Pharmaceuticals, Inc. (RYTM) Q2 Earnings Expected to Decline
Other News for PRTA
PRTA forms 20 Day Moving Average Resistance on September 18
Is PRTA ready to make a move? NR7 shows up after a flat session
PRTA forms NR7 on September 15
Is PRTA primed for downward momentum? Fell Below 20 Day Moving Average shows up after declining 2.61%
Crossed Above 20 Day Moving Average appears for PRTA after 1.51% move